FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080490516> ?p ?o ?g. }

• W2080490516 endingPage "83" @default.
• W2080490516 startingPage "76" @default.
• W2080490516 abstract "In Brief Objective: The aim of this study was to determine the role of antithrombin III (AT-III) in portal vein thrombosis (PVT) after splenectomy in cirrhotic patients. Summary Background Data: There is no standard treatment for PVT after splenectomy in liver cirrhosis. Methods: A total of 50 consecutive cirrhotic patients who underwent laparoscopic splenectomy for hypersplenism were enrolled into this study. From January 2005 to December 2005, 25 cirrhotic patients received no prophylactic anticoagulation therapy after the operation (AT-III [−] group). From January 2006 to July 2006, 25 cirrhotic patients received prophylactic administration of AT-III concentrates (1500 U/d) on postoperative day (POD) 1, 2, and 3 (AT-III [+] group). Results: In AT-III (−) group, 9 (36.0%) patients developed PVT up to POD 7, and risk factors for PVT were identified as: low platelet counts, low AT-III activity, and increased spleen weight. Although there were no significant differences in the clinical characteristics, including the above risk factors, between the 2 groups, only 1 (4.0%) patient developed PVT on POD 30 in AT-III (+) group, and the incidence of PVT was significantly lower than in AT-III (−) group (P = 0.01). In AT-III (−) group, AT-III activity was significantly decreased from POD 1 to POD 7, as compared with the preoperative level, whereas AT-III concentrates prevented the postoperative decrease in AT-III activity. Conclusions: These results demonstrate that low AT-III activity and further decreases in this activity are associated with PVT after splenectomy in cirrhotic patients, and that treatment with AT-III concentrates is likely to prevent the development of PVT in these patients. We investigated the impact of prophylactic treatment with antithrombin III (AT-III) concentrates on portal vein thrombosis (PVT) after laparoscopic splenectomy in liver cirrhosis. Although in 25 patients without AT-III prophylaxis, 9 (36.0%) patients developed PVT and in 25 patients with AT-III prophylaxis, only 1 (4.0%) patient developed PVT (P = 0.01)." @default.
• W2080490516 created "2016-06-24" @default.
• W2080490516 creator A5003319662 @default.
• W2080490516 creator A5004420462 @default.
• W2080490516 creator A5011469949 @default.
• W2080490516 creator A5016201917 @default.
• W2080490516 creator A5050131473 @default.
• W2080490516 creator A5055920688 @default.
• W2080490516 creator A5059498080 @default.
• W2080490516 creator A5059711489 @default.
• W2080490516 creator A5061248086 @default.
• W2080490516 creator A5072153400 @default.
• W2080490516 creator A5077589221 @default.
• W2080490516 creator A5083643100 @default.
• W2080490516 date "2010-01-01" @default.
• W2080490516 modified "2023-09-23" @default.
• W2080490516 title "Impact of Antithrombin III Concentrates on Portal Vein Thrombosis After Splenectomy in Patients With Liver Cirrhosis and Hypersplenism" @default.
• W2080490516 cites W1585201356 @default.
• W2080490516 cites W1899900926 @default.
• W2080490516 cites W1963731698 @default.
• W2080490516 cites W1976756670 @default.
• W2080490516 cites W1985344784 @default.
• W2080490516 cites W2007242727 @default.
• W2080490516 cites W2007296276 @default.
• W2080490516 cites W2011557656 @default.
• W2080490516 cites W2026147737 @default.
• W2080490516 cites W2029290028 @default.
• W2080490516 cites W2029497230 @default.
• W2080490516 cites W2038287002 @default.
• W2080490516 cites W2040992627 @default.
• W2080490516 cites W2041083919 @default.
• W2080490516 cites W2042153013 @default.
• W2080490516 cites W2042531763 @default.
• W2080490516 cites W2042616062 @default.
• W2080490516 cites W2043486227 @default.
• W2080490516 cites W2043656046 @default.
• W2080490516 cites W2044294612 @default.
• W2080490516 cites W2046449262 @default.
• W2080490516 cites W2048441761 @default.
• W2080490516 cites W2053776083 @default.
• W2080490516 cites W2058122407 @default.
• W2080490516 cites W2059883429 @default.
• W2080490516 cites W2068068809 @default.
• W2080490516 cites W2074301109 @default.
• W2080490516 cites W2085280114 @default.
• W2080490516 cites W2088046793 @default.
• W2080490516 cites W2093567657 @default.
• W2080490516 cites W2093704110 @default.
• W2080490516 cites W2093904358 @default.
• W2080490516 cites W2104674370 @default.
• W2080490516 cites W2117488191 @default.
• W2080490516 cites W2118529414 @default.
• W2080490516 cites W2135283537 @default.
• W2080490516 cites W2144936227 @default.
• W2080490516 cites W2145245006 @default.
• W2080490516 cites W2145679995 @default.
• W2080490516 cites W2161090555 @default.
• W2080490516 cites W2163645105 @default.
• W2080490516 cites W2292358003 @default.
• W2080490516 cites W2419227221 @default.
• W2080490516 cites W2466191110 @default.
• W2080490516 cites W2469056706 @default.
• W2080490516 doi "https://doi.org/10.1097/sla.0b013e3181bdf8ad" @default.
• W2080490516 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19864937" @default.
• W2080490516 hasPublicationYear "2010" @default.
• W2080490516 type Work @default.
• W2080490516 sameAs 2080490516 @default.
• W2080490516 citedByCount "89" @default.
• W2080490516 countsByYear W20804905162012 @default.
• W2080490516 countsByYear W20804905162013 @default.
• W2080490516 countsByYear W20804905162014 @default.
• W2080490516 countsByYear W20804905162015 @default.
• W2080490516 countsByYear W20804905162016 @default.
• W2080490516 countsByYear W20804905162017 @default.
• W2080490516 countsByYear W20804905162018 @default.
• W2080490516 countsByYear W20804905162019 @default.
• W2080490516 countsByYear W20804905162020 @default.
• W2080490516 countsByYear W20804905162021 @default.
• W2080490516 countsByYear W20804905162022 @default.
• W2080490516 countsByYear W20804905162023 @default.
• W2080490516 crossrefType "journal-article" @default.
• W2080490516 hasAuthorship W2080490516A5003319662 @default.
• W2080490516 hasAuthorship W2080490516A5004420462 @default.
• W2080490516 hasAuthorship W2080490516A5011469949 @default.
• W2080490516 hasAuthorship W2080490516A5016201917 @default.
• W2080490516 hasAuthorship W2080490516A5050131473 @default.
• W2080490516 hasAuthorship W2080490516A5055920688 @default.
• W2080490516 hasAuthorship W2080490516A5059498080 @default.
• W2080490516 hasAuthorship W2080490516A5059711489 @default.
• W2080490516 hasAuthorship W2080490516A5061248086 @default.
• W2080490516 hasAuthorship W2080490516A5072153400 @default.
• W2080490516 hasAuthorship W2080490516A5077589221 @default.
• W2080490516 hasAuthorship W2080490516A5083643100 @default.
• W2080490516 hasConcept C120665830 @default.
• W2080490516 hasConcept C121332964 @default.
• W2080490516 hasConcept C126322002 @default.
• W2080490516 hasConcept C141071460 @default.
• W2080490516 hasConcept C2776309230 @default.

• next